To better treat people with depression, not only must we treat the neurons affected by the disease, but we must also restore the integrity of the barrier that regulates exchanges between blood circulation and the brain.
This is the conclusion of a study published today in PNAS by Université Laval researchers and their international collaborators.
“Between 30% and 50% of those suffering from depression respond either poorly or not at all to antidepressants,” says main author Caroline Ménard, professor at Université Laval’s Faculty of Medicine and researcher at the Cervo Brain Research Centre.
“This suggests that biological mechanisms other than those directly affecting neurons are at play,” adds professor Ménard, who also holds the Sentinel North Research Chair on the Neurobiology of Stress and Resiliency.
Caroline Ménard and her colleagues showed in 2017 that the appearance of depressive symptoms in mice subjected to social stress was linked to increased permeability of the blood-brain barrier. They also discovered that this permeability is due to a decrease in a protein called claudin-5.
“In the study published today, we wanted to find out what causes the decrease in claudin-5 in mice under social stress and why some mice are resilient to social stress while others exhibit depressive symptoms,” explains Professor Ménard.
The researchers examined blood-brain barrier cells in depressed stressed mice, resilient stressed mice, and control mice. Their observations show that the epigenetic processes that allow the expression of the claudin-5 gene are more readily activated in resilient mice. They also observed that the resilient mice produce less of one of the proteins that inhibit expression of the claudin-5 gene.
Conversely, depressed stressed mice express more of an enzyme called HDAC1 that triggers a loss of claudin-5. “When a chemical compound is used to block HDAC1, the depressive mice produce more claudin-5 and their social interactions spontaneously increase,” says Professor Ménard.
Thanks to the Douglas Bell Canada Brain Bank, the researchers were able to verify whether the same mechanisms were present in humans.
“We found that expression of HDAC1 was greater in depressed people without treatment at the time of death than in subjects who were taking antidepressants or in the control group. This increase correlated with a decrease in claudin-5.”
Conversely, depressed stressed mice express more of an enzyme called HDAC1 that triggers a loss of claudin-5. “When a chemical compound is used to block HDAC1, the depressive mice produce more claudin-5 and their social interactions spontaneously increase,” says Professor Ménard.
These results suggest that efforts to develop better treatments for depression should not be limited to finding new molecules that target affected neurons. Researchers must also find a way to close the gaps in the blood-brain barrier to ensure its proper functioning.
“For now, we don’t know of any molecules that increase the expression of claudin-5 and would allow us to directly restore the barrier’s impermeability,” adds Professor Ménard. “Our future work will focus on evaluating the effect of different pharmacological approaches and lifestyle habits on the integrity of this barrier in order to promote resilience.”
The authors of the study are Katarzyna Dudek, Laurence Dion-Albert, Manon Lebel, Simon Labrecque, Ellen Tuck, and Caroline Ménard (Université Laval); Katherine LeClair, Carmen Ferrer Perez, Sam Golden, and Scott Russo (Icahn School of Medicine at Mount Sinai); Carol Tamminga (University of Texas Southwestern Medical Center); and Gustavo Turecki and Naguib Mechawar (McGill University).
The blood-brain barrier (BBB) separates the central nervous system (CNS) from the peripheral tissues. In order to maintain homeostasis in the CNS, the BBB controls material, nutrients and cell transfer from the blood to the brain and from the brain to the blood. The BBB restricts the entry of peripheral inflammatory mediators (e.g. cytokines, antibodies, etc.), which can impair neurotransmission [1]. The BBB also participates in the clearance of cellular metabolites and toxins from the brain to the blood [2, 3] and regulates the composition and volume of the cerebrospinal fluid.
The BBB is a complex structure consisting of endothelial cells, pericytes, vascular smooth muscle cells, astrocytes, microglia and neurons [2, 4–7] as is located between the brain parenchyma and the vascular system.
Interactions between these components have led to the concept of the neurovascular unit, where each cell type contributes to BBB function [8]. The main structures responsible for the barrier properties of the BBB are tight junctions (TJs) [9–15]. The maintenance of adherence, gap and tight junctions between different cell types within the neurovascular unit of the BBB is essential for CNS homeostasis [2, 16]. BBB disturbances commonly occur in neuronal dysfunction, neuroinflammation and neurodegeneration [2].
Numerous pathologic states can cause disturbances in the BBB, including trauma, hypoxia, infection, activation of the clotting system, inflammation, dietary components, environmental toxins and genetic factors [17].
The association between high-grade inflammatory responses such as meningitis, encephalitis, sepsis, local and systemic infections and increased permeability of the BBB for many substances and immune cells has been widely acknowledged [18]. Recently, it became apparent that low-grade systemic inflammation also substantially affects the BBB [19].
Low-grade inflammation affects about 40% of the population in Western countries, as it occurs due to metabolic syndrome, insulin resistance, type 2 diabetes, arterial hypertension, dyslipidaemia and obesity [20–22].
BBB disruption refers to a reduction in barrier tightness and an increase in leakiness. Loss of BBB integrity allows for the entrance of cytokines and immune cells into the CNS, which activates glial cells and causes the alterations in the extracellular environment. Moreover, these changes lead to secondary inflammation and further damage to the BBB, with the leakage of plasma proteins and neurotoxic substances [23, 24].
CNS inflammation determines the severity and disease course of numerous psychiatric and neurological disorders and can be both caused by and result from BBB dysfunction; an inflammatory response in the brain might lead to endothelial cell damage and increased BBB permeability [25].
The permeability of the BBB is altered in many CNS pathologies, including brain injury, ischemic stroke, multiple sclerosis (MS), epilepsy, Parkinson’s disease, Alzheimer’s disease and major depression. A connection has also been reported between BBB impairment and psychiatric disorders such as mood disorders, psychosis, autism spectrum disorder and even chronic sleep disorder [1, 26–29].
It has been well discussed in the literature that inflammatory mechanisms are related to the physiopathology of neuropsychiatric disorders through several mechanisms. Among them are glial activation [30], neuronal damage and degeneration [31], increased oxidative stress [32], reduced neurotrophic support [33], altered neurotransmitter metabolism [34] and BBB disruption [35].
Exercise training is an important behavioural intervention that has numerous beneficial health effects. Epidemiological studies indicate that physical activity leads to systemic adaptations and an elongated health-span, thus time of life in good health, in different human cohorts [36, 37]. Ample evidence suggests that the practice of physical exercise improves some cardiovascular risk factors, such as the percentage of body fat, insulin resistance and high blood pressure, which are associated with increased stiffening of the arteries [38]. Moreover, it has been shown that physical exercise has an impact on inflammation and improved endothelial function by increasing blood flow, which leads to increased shear stress, stimulating the release of nitric oxide.
In this narrative review, we aim to provide a state-of-the-art summary of the influence of exercise on BBB integrity. Consequently, we discuss the influence of physical activity on systemic inflammation, the brain renin-angiotensin and noradrenergic systems and central autonomic function, as well as the kynurenine pathway. There are numerous mechanisms through which long-term physical activity affects the BBB and CNS. It can either diminish inflammation on the peripheral level, thereby reducing the risk of CNS infiltration of immune cells, or protect the BBB through the constitution of its tight junctions.
Exercise and systemic inflammation
Diabetes mellitus and obesity are exemplar diseases characterised by low-grade inflammation [39, 40]. Notably, inflammation and metabolic dysfunction are frequently associated with oxidative stress in adipose depots [41–43]. Overweight and obese patients with a diagnosis of type 2 diabetes mellitus show increased blood levels of pro-inflammatory cytokines and markers (e.g. IL-1β, IL-6 and TNF-α) [44–46].
These molecules are also increased in the brain, cerebrospinal fluid and in the blood of patients with Alzheimer’s disease or other types of dementia [47]; moreover, an overlap between the pathogenesis of Alzheimer’s disease and diabetes mellitus is evident.
Pro-inflammatory cytokines can pass through the BBB and induce stress-activated pathways, promoting brain insulin resistance, mitochondrial dysfunction [19] and the accumulation of neurotoxic beta-amyloid (Aβ) oligomers [48] leading to synaptic loss, neuronal dysfunction and cell death. Increased ceramide production caused by dysregulated lipid metabolism also occurs with insulin resistance [49]; these molecules can pass through the BBB, induce pro-inflammatory reactions and disturb brain insulin signalling [50].
Physical training may be crucial in preventing as well as diminishing this damage. Regular physical exercise reinforces antioxidative capacity, reduces oxidative stress and has anti-inflammatory effects. It improves endothelial function and might increase the density of brain capillaries.
Physical training can further counteract dyslipidaemia and reduce increased ceramide levels [51, 52], and it may have a suppressive effect on the BBB damage cycle. Abd El-Kader et al. [53] presented data that both endurance and strength training can potentially alleviate the inflammatory state due to a reduction in TNF-α levels in type 2 diabetes mellitus patients.
De Senna et al. [54] have also demonstrated that exercise improves the structural components of the BBB in diabetic rats. Regular exercise training induces a reduction in adipose tissue-derived pro-inflammatory cytokines like IL-6, TNF-α and MCP-1[55–58], which are associated with low-grade systemic inflammation and provides reduction in whole-body insulin resistance [59].
Importantly, physical activity is able to decrease inflammation independently from weight loss, through a reduction in inflammatory cytokines release from skeletal muscles. Similar to adipose tissue as well as immune cells, skeletal muscle, which is the largest organ in the human body, produces and releases inflammatory cytokines such as IL-4, IL-6, IL-8, IL-15 and TNF-α [60–62].
These cytokines are therefore also called myokines [60, 63]. Handschin and Spiegelman [64] hypothesised that physical activity can broadly suppress myokine expression through the upregulation of skeletal muscle peroxisome proliferator activated receptor 1α. The upregulation of this receptor is induced by physical activity [65]. In a study by Aronson et al. [66], C-reactive protein (CRP) concentrations decreased continuously with increasing levels of physical fitness. Increases in circulating IL-6 have been observed after performing exercise without muscle damage; this in turn reduces pro-inflammatory cytokines via the stimulation of the anti-inflammatory cytokines IL-1ra and IL-10 [61].
A recent study by Chupel et al. [67] showed that physical exercise can maintain BBB integrity. The anti-inflammatory effect of combined exercise training and taurine supplementation on peripheral markers of BBB integrity, inflammation and cognition in 48 elderly women was investigated. The results showed a reduction in TNF-α and IL-6, as well as a reduction in the IL-1β/IL-1ra, IL-6/IL-10 and TNF-α/IL-10 ratios in the combined exercise training group. Interestingly, the improvement in cognitive function was reported only in women subjected to both exercise and taurine augmentation.
Exercise and kynurenine pathway
Brain and peripheral inflammatory states can also promote BBB failure through tryptophan (TRP) catabolism as a consequence of kynurenine pathway activation, which is also connected with glutamatergic excitotoxicity. Tryptophan is metabolised via several pathways, the main one being through kynurenine (KYN) [68], which is involved in several conditions including cancer, inflammatory disorders, diabetes mellitus, neurological and neurodegenerative diseases. Tryptophan is degraded into kynurenine by the enzyme indoleamine 2,3-dioxygenase (IDO) [69, 70]. Kynurenine is then metabolised into neuroprotective kynurenic acid (KYNA) by kynurenine aminotransferases (KATs) or into neurotoxic products such as quinolinic acid (QUIN) or anthranilic acid.
QUIN is a selective agonist of N-methyl-d-aspartate (NMDA) receptors, and a potent neurotoxin due to its ability to induce the production of reactive oxygen species. KYN reduces the activity of natural killer cells, dendritic cells or proliferating T cells, whereas KYNA promotes monocyte extravasation and controls cytokine release. High levels of QUIN have been associated with neuronal excitotoxicity, whereas KYNA has been reported as a neuroprotective factor [71] through its inhibitory action at glutamatergic excitatory synapses [72]. Among the kynurenine pathway metabolites, QUIN is likely to be one of the most important in terms of biological activity and toxicity [73]. Both KYNA and QUIN have been found to be dysregulated in major depressive disorders and schizophrenia [74]. Pro-inflammatory mediators such as TNF-α can promote QUIN production [75], while IL-1β potentiates quinolinate-mediated excitotoxicity [68].
This is particularly important in situations involving macrophage infiltration across the BBB. In CNS inflammatory states, IDO is mainly activated in microglial cells, which preferentially metabolise tryptophan into the NMDA receptor agonist QUIN. The most potent activator of IDO is interferon gamma (IFN-γ) [70, 76]. Therefore an imbalance in type 1/type 2 immune responses, associated with an astrocyte/microglia imbalance, leads to serotonergic deficiency and glutamatergic overproduction. Astrocytes are further strongly involved in the re-uptake and metabolic conversion of glutamate.
A reduced number of astrocytes could contribute to both diminished counter-regulation of IDO activity in microglia and altered glutamatergic neurotransmission. Binding of excess glutamate to dysregulated BBB endothelial cell ionic NMDA receptors and metabotropic glutamate receptors can increase intracellular Ca2+-dependent oxidative stress and BBB permeability by increasing Ca2+ influx and release from endoplasmic reticulum stores, respectively.
Skeletal muscle has recently been added [77] to the list of tissues that contribute to kynurenine pathway metabolism. This happens in the setting of exercise training, which enhances KAT gene expression and the conversion of toxic KYN to neuroprotective KYNA. The neuroprotective effect of KYNA is generally attributed to its antagonistic action on NMDA receptors.
It has been found by András and colleagues [78] that a high glutamate level diminishes the function of the BBB via endothelium-expressed NMDA receptor-dependent occludin phosphorylation. KYNA is not only an endogenous NMDA receptor blocker but also a non-competitive inhibitor of the α7-nicotinic acetylcholine receptor [68, 79, 80]; through this mechanism, KYNA can decrease glutamate release [81]. In this manner, KYNA can reduce pathological glutamate levels and protect the structure of the BBB [78]. The effect of exercise training on the BBB highlights an important mechanism of inter-organ cross-talk as kynurenine accumulation can be suppressed by activating its clearance in exercised skeletal muscles.
Exercise and the renin-angiotensin-aldosterone pathway
There is a linkage between angiotensin II (Ang II), one of the renin-angiotensin-aldosterone factors, and the disruption of the BBB, especially in hypertension states [82–84]. Although Ang II is known as a cardiovascular mediator, with a primary role in the regulation of blood pressure and fluid homeostasis [85], it performs as an immune system modulator as well. Ang II can initiate inflammation by indirect promotion of vascular permeability and the recruitment of inflammatory cells [86]. Ang II may also activate both innate and adaptive immunity [86, 87].
Ang II directly modulates transcytotic and paracellular permeability in BBB endothelial cells and could contribute to the pathophysiology of hypertensive encephalopathy. Both circulating Ang II via Ang II type 1 receptors (AT1) on the endothelium and locally synthesised Ang II can result in vascular dysfunction and microglial activation, increase the production of reactive oxygen species, disrupt endothelial nitric oxide synthase activity and intensify pro-inflammatory cytokine synthesis, which are important factors for sympathoexcitation centres such as the paraventricular nucleus (PVN) of the hypothalamus and the rostral ventrolateral medulla (RVLM) in neurogenic hypertension [88–90]. However, one study has indicated that inhibition of AT1 blocks hypertension-related increases in cell permeability and cerebral oedema, even in the absence of lowered blood pressure [91].
This suggests a role for the renin-angiotensin-aldosterone system and Ang II in modulating BBB function. BBB disruption not only facilitates Ang II access but also allows circulating inflammatory cells to enter into the brain parenchyma, contributing to further microglial activation and inflammation in autonomic areas such as the PVN of the hypothalamus and the RVLM [89, 90]. These responses alter neurovascular coupling, dysregulate cerebral perfusion and markedly augment neuronal discharge, thus exacerbating sympathoexcitation in hypertensive animals [83, 92, 93].
Physical exercise has been shown to be highly efficient in reducing the harmful effect of hypertension on BBB leakage in autonomic brain areas, which strongly correlates with the improvement of both parasympathetic and sympathetic control of cardiovascular parameters, even in the persistence of hypertension. Recent studies have established the efficacy of aerobic training to downregulate the brain renin-angiotensin system and correct autonomic dysfunction in spontaneously hypertensive rats [94, 95]. These rats, after 2 weeks of physical exercise, have been reported to maintain normal angiotensinogen expression within autonomic areas, which is correlated with reduced sympathetic outflow to the heart and vessels and precedes a partial fall in arterial pressure [96].
Exercise training restores the balance between the excitatory and inhibitory neurotransmitters as well as between pro- and anti-inflammatory cytokines, and attenuates oxidative stress in the PVN [97]. Trained spontaneously hypertensive rats demonstrate an instant normalisation of the baroreceptor reflex control of heart rate that coincides with a marked reduction in oxidative stress and inflammation in the hypothalamic PVN [98]. Similar training-induced effects have also been observed in other autonomic areas [94, 95].
It is already known that acute physical activity induces sympathetic modulation [99]. Conversely, regular exercise may be associated with progressive sympathetic withdrawal and increasing parasympathetic dominance as a result of adaptations of the peripheral and central regulatory systems [99]. It has been shown that hypertension is characterised by autonomic impairment, BBB leakage and Ang II-induced neuronal activation and that exercise training is highly effective at preventing Ang II-induced effects and improving autonomic function [100].
Physical training changes the tissue Ang II content as well and suppresses microglial activation, crucial factors for both the maintenance of BBB integrity and the normalisation of autonomic control of the circulation in hypertensive individuals. According to some authors, there may be a system of global control over the permeability of the cerebral microvasculature via the cholinergic nervous system [101]. Due to the fact that exercise induces a shift toward parasympathetic dominance, this mechanism may also be favoured.
There is an interaction between neurotransmitters, pro-inflammatory cytokines and enhanced oxidative stress in the PVN which play a key role in sympathetic regulation of blood pressure [95]. In spontaneously hypertensive rats, reactive oxygen species in the RVLM are known to enhance glutamatergic excitatory inputs and impair GABAergic inhibitory inputs to the RVLM, resulting in increased sympathoexcitatory input to the RVLM from the PVN [102].
Among the known pressor agents, Ang II and glutamate play pivotal roles in the brain centres involved in blood pressure control in both normotensive and spontaneously hypertensive rats [103]. The link between brain angiotensinergic and glutamatergic signalling has been demonstrated by Vieira et al. [104]. The major sympathetic output pathway for the tonic and reflex control of blood pressure, which uses glutamate as a transmitter, arises in the RVLM [105].
Injection of Ang II into the RVLM of unanaesthetised rats exaggerates the pressor response to glutamate. Additionally, it has been speculated that Ang II takes part in glutamate pressor responses via a presynaptic increase in glutamatergic input into the RVLM [106]. Referring to this, KYNA (a glutamate antagonist) is thought to be a hypotensive agent. Mills et al. [107] have reported that intrathecal KYNA administration decreases blood pressure, especially in anesthetised spontaneously hypertensive rats and stroke-prone spontaneously hypertensive rats, with a less noticeable effect in normotensive rats.
It can be assumed that in hypertension states, there is an ability of physical exercise to correct sympathetic hyperactivity, reduce Ang II availability, decrease oxidative stress and inflammation in the PVN and RVLM and restore BBB integrity.
Exercise and brain noradrenergic system
During physical exercise, it is well known that peripherally circulating epinephrine and norepinephrine (NE) activate β-adrenoceptors of the vagus nerve afferents projecting to the locus coeruleus, which plays a pivotal role in the regulation of autonomic activity and cognitive functions [108–112]. The optimal stimulation of locus coeruleus might be a crucial element of modulating cognitive function with exercise [113]. Brain NE is also reported to suppress the inflammatory gene transcription.
It is clear from the findings of Hetier et al. [114] and Frohman et al. [115] that anti-inflammatory action of NE is exerted via microglia and astrocytes β2-receptors. Immune cells express both types of receptors, and T and B lymphocytes express β2-receptors almost exclusively [116]. Engagement of β2-receptors activates a cascade of signaling intermediates, including cyclic adenosine monophosphate (cAMP) and protein kinase A, which leads to the phosphorylation of cellular proteins [116]. NE also promotes a shift of Th1/Th2 balance toward Th2 response by activating β2-receptor [117].
Other anti-inflammatory effects of NE have also been reported, including the suppression of inducible nitric oxide synthase, interleukin-1b, tumor necrosis factor α and intercellular adhesion molecule-1. Attention is also devoted to the fact that NE enhances brain-derived neurotrophic factor production, which plays an important role in neuronal survival, neuroplasticity and neurogenesis [37, 118]. This interaction of brain-derived neurotrophic factor is mediated by β1/β2, and α2-adrenergic receptors and shares similar cellular pathways with anti-inflammatory NE action [118–120].
Neurons metabolize glucose primarily in the pentose phosphate pathway in order to produce adenosine triphosphate (ATP) to support brain functions, including glutathione regeneration, which protects the neuron from reactive oxygen species (Bélanger et al. 2011), and consequently stands for proper BBB functioning.
Apart from using glucose as the first choice, lactate is also used by the brain as a fuel for neurons [121, 122]. This process occurs in the astrocytes, where the recruitment of energy from their glycogen stores [123] is facilitated by noradrenergic stimulation of the astrocytes’ β-adrenoceptors signaling them to convert glycogen to lactate [124, 125], which is then transported to the neurons [126].
In response to physical exercise, the lactate production by skeletal muscles increases [127, 128], as does the expression of the lactate transporter monocarboxylate transporter 1 at the BBB [129–131]. Lactate produced during exercise is also reported to increase levels of growth factors important to angiogenesis, neurogenesis, calcium signaling, axonal myelination, synaptic plasticity and memory formation [132–134]. Energetic insufficiency in neurons due to inadequate lactate supply is implicated in several neuropathologies, including attention-deficit/hyperactivity disorder [135–137].
Exercise in multiple sclerosis
MS has recently attracted the interest of numerous researchers [138] regarding the application of physical activity. In MS, there is an extrinsic BBB disruption pattern with the initial injury in the blood vessels, allowing T and B cells to cross the BBB [139] with the exudation of fibrin, which causes an inflammatory reaction leading to demyelination [140], immune cell infiltration and axonal damage. In accordance with a study by Mokhtarzade et al. [141], it has been shown that 8 weeks of exercise training normalises the concentration of particular BBB permeability markers in MS patients, including S100 calcium-binding protein B (S100B). Additionally, according to White et al. [142], exercise is potentially able to counteract the imbalance between the pro-inflammatory Th1 cytokines and the anti-inflammatory cytokines (for example IL-10) by enhancing anti-inflammatory mechanisms in MS patients.
According to Rossi et al. [143], exercise can protect from inflammation-induced neurodegenerative synaptic and dendritic alterations in the experimental autoimmune encephalomyelitis mouse model of MS. In this study, exercise has been shown to increase synaptic density and growth in the hippocampus [143]. In animal model of MS, positive effects of exercise upon cognition are also reported [144, 145]. Moreover, an increase in neurotrophins [145] and brain-derived neurotrophic factor [146] in response to exercise has been found.
However, there is still an urge for human researches. The analyses of studies indicate that ideally both aerobic and resistance exercises may benefit persons with MS. A substantial increase in hippocampal volume has been reported in MS subjects randomized to an aerobic exercise program compared with a nonaerobic-trained control [147]. Physical fitness exercise correlates with improved cognitive function in persons with MS [148, 149]. Another finding indicates that cardiorespiratory fitness in patients with MS predicts neuronal plasticity [150] and increased gray matter volume, better white matter integrity and improved performance on test of information processing speed [151]. There is some evidence for neuroprotective effects of exercise in humans with MS, comparing aerobic to aerobic plus resistance exercise training resulting in decreases in anti-inflammatory cytokines [148].
Based on these findings, it can be postulated that physical exercise reduces inflammation and, as a consequence, BBB impairment, and thus has a protective effect on CNS in MS patients. If physical activity is able to enhance BBB stability in these particular patients, we can predict that it will improve BBB function in general. Nevertheless, studies with larger group of patients and clearly developed exercise protocols are needed to include physical activity sessions as a standard of care therapeutic procedures.
Exercise in Alzheimer’s disease
In Alzheimer’s disease, the integrity of BBB may be disordered according to accumulation of reactive oxygen species activating metalloproteinases which leads to breakdown of BBB through destruction of basement membrane and tight junctions [152], as well as due to the accumulation of cholesterol metabolism [152], and impaired insulin signaling [153].
In the prevalence of BBB maintenance complications, the amplified Aβ microvessels deposits process begins. As Aβ fibrils accumulate, it results in a cascade of significant brain degeneration and atrophy of hippocampal and cortical structures. BBB dysfunction during Alzheimer’s disease influences Aβ clearance and endothelial transport, impairs endothelial cell and pericyte functions, affects TJ integrity, activates glial cells and facilitates the recruitment of leukocytes in the brain [154–158].
Physical activity can improve Aβ clearance by upregulating Aβ transporters and reduce the accumulation of Aβ peptides in the brain parenchyma by accelerating interstitial fluid drainage, which diminishes neuroinflammation [159]. Although a direct effect on specific Alzheimer’s disease pathology is still unproven [160], one research documented a reduction in tau in cerebrospinal fluid as a result of exercise in older adults with mild cognitive impairment [161]. Exercise, primarily aerobic, improves cognitive function in several patient populations, including Alzheimer’s disease, elderly people at risk for cognitive impairment and healthy older adults [162, 163].
In addition, both animal and humans studies suggest that physical activity may have a role in modifying the disease process and maintaining cognitive function in Alzheimer’s disease [11]. Physical activity interventions has a positive overall effect on cognitive function, and the effect is driven by interventions that included aerobic exercises independent of the type of dementia [164], which has been recently proved in meta-analysis conducted by Öhman et al. [165].
Further studies shall unveil if/how neuroinflammation and BBB dysfunction are related to cognitive function impairment and overall Alzheimer’s disease progression. Then, specific physical activity protocols may be developed to support patients care.
Exercise-induced conditioning
Physical activity acutely elevates the release of adrenaline, cortisol, growth hormone, prolactin and other factors with immunomodulatory effects [166]. Consequently, very high intensity exercise can trigger systemic inflammation, a subsequent immunodepression and thus a higher risk of infections [167]. According to Roh et al. [168], moderate- and/or high-intensity exercise may induce higher oxidative-nitrosative stress than low-intensity exercise.
While acute intense exercise provokes a spike in the activity of inflammatory cells (like leukocytes) and plasma CRP concentrations, repeated bouts of submaximal intensity exercise induce adaptive mechanisms that can counteract inflammation in the long term [169]. These changes are measurable as reduction in the concentration of inflammatory mediators such as CRP, IL-6 and TNF-α, while enhancing the productions of the anti-inflammatory IL-10 [170].
There are some contrasting studies regarding the influence of physical exercise on BBB integrity. S100B is considered to be the best indicator of BBB permeability [168, 171, 172] and can even predict the severity of brain injury [168, 173]. Elevated S100B levels have been recorded following exercise and are mostly attributed to either an elevation in BBB permeability or head trauma [174–176].
Increased serum concentrations of S100B have therefore been used to associate CNS pathology with BBB dysfunction. However, even in the absence of head trauma, it appears that the BBB may be compromised following exercise, with the severity dependent on exercise intensity.
According to Sharma et al. [177], short-term forced swimming exercise increases the permeability of the BBB in specific brain regions in rats, likely mediated through serotonin via 5-HT2 receptors. Intense exercise has the potential to increase S100B and induce BBB functional deterioration without causing structural brain damage subsequent to a free radical-mediated impairment in dynamic cerebral autoregulation [178].
After acute exercise, high levels of myokines are secreted by the skeletal muscle, exerting a variety of endocrine effects. The induction of myokines like myostatin, IL-7, decorin and leukaemia inhibitory factor is involved in the regulation of muscle hypertrophy and may play a role in the restructuring of skeletal muscle as a response to exercise [179].
Exercise reduces the expression of Toll-like receptors at the surface of monocytes; these receptors have been implicated as mediators of systemic inflammation [180]. Muscle function, inflammation and exercise are hence intrinsically linked in a complex manner [64, 181].
The induction of the beneficial versus detrimental effects of physical activity therefore seems to be highly context-specific. For example, IL-6 was originally classified as a prototypical pro-inflammatory cytokine, although anti-inflammatory properties have also been described [182].
Some studies have provided data showing an increase in IL-6 concentrations directly after physical activity, suggesting that IL-6 was released from the muscle mass and acts as a myokine, rather than a typical pro-inflammatory cytokine [183].
Besides the production of IL-6 in activated immune cells, the systemic elevation of IL-6 in patients with metabolic diseases has strengthened the link between IL-6 and inflammation.
In stark contrast, however, exercise-induced elevations in IL-6 plasma levels lead to increased circulating levels of several potent anti-inflammatory cytokines such as IL-1ra and IL-10, and also inhibit TNF-α production, suggesting that IL-6 may also have anti-inflammatory properties [184, 185]. Skeletal muscle fibres also express and release IL-6 during and after exercise [186–189]. IL-6 production is likewise boosted in connective tissue, the brain and adipose tissue post-exercise [60].
Thus, in the case of exercise, IL-6 exerts anti-inflammatory effects [63]. This mechanism may explain why lower baseline levels of pro-inflammatory cytokines are present in those people who are most physically active [190]. Cells respond to the stressful stimulus of exercise by activating pathways to abolish it; in this case, by increasing the expression of enzymes such as superoxide dismutase and glutathione peroxidase or by increasing levels of anti-oxidative peroxiredoxins.
A likely mediator of this response are proteins related to the NFκB pathway, which can activate the gene expression of anti-oxidative proteins and show enhanced DNA binding around 2 h after acute exercise [191, 192]. Consequently, physical activity reduces the production of reactive oxygen species and enhances the anti-oxidative defence [193, 194]. In skeletal muscle in particular, repeated moderate intensity exercise improves the anti-oxidative capacity by upregulating endogenous anti-oxidative molecules [195, 196].
Thus, we can assume that brief, intense physical activity increases the permeability of the BBB [177] and induces inflammation, but long-term regular exercise may have a protective role on BBB integrity and activate anti-inflammatory pathways.
Physical Exercise and BBB tight junctions
The BBB is composed of endothelial cells forming a selective vascular network through the expression of tight junction (TJs) complexes, which are defined as molecules that interact in the extracellular junctional space or as molecules that act as anchors within the endothelial cell to create the BBB [174].
Tight junctions between brain endothelial cells are constituted by three major transmembrane proteins: occludin, claudins and junction associated molecules, as well as several cytoplasmic proteins including zonula occludens [197]. Brain endothelial TJs express claudin-3 and -5 and possibly claudin-12 [198, 199]. Claudin-5 has been shown to actively contribute to BBB integrity [200]. Many studies have indicated that occludin, claudin-3 and claudin-5 are involved in BBB genesis [199, 201] and the control of paracellular permeability [202–205].
TJs can be regulated by the activation of various receptors of vasoactive compounds (bradykinin and Ang II) as well as adhesion molecules or reactive oxygen species. Intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and platelet and endothelial cell adhesion molecule 1 (PECAM-1), members of the immunoglobulin superfamily, actively contribute to the firm adhesion and/or migration of leukocytes into the CNS through the cytokine-activated brain endothelium [206, 207].
Agents released from most of the cells of the neurovascular unit during pathology can modulate brain endothelial tight junctions, with several inflammatory mediators exacerbating BBB permeability; only a few agents are able to counter or reverse this course [1]. The prolonged presence of oxidative/inflammatory factors can result in changes to or the loss of tight junctions and integrins (e.g. β1, αv and α6 integrins), leading to senescence and detachment-mediated cell death [23, 208]. It is known that both IFN-γ and TNF-α can alter BBB permeability by affecting the cellular distribution of junctional adhesion molecules and by crucial upregulating the expression of ICAM-1 and VCAM-1 [209–211].
Changes in BBB permeability are connected with alterations in occludin expression [212] and endothelial barrier function [202]. The selectivity of claudin-5 expression in brain endothelial cells suggests that it is essential for BBB function [213], as it has been demonstrated that claudin-5 participates in modulating permeability to ions as well as macromolecules [214]. Several studies have indicated that altered permeability of the BBB is accompanied by decreased claudin-5 expression [213].
Attention should be also devoted to recent research by Souza et al. [215] regarding the impact of physical exercise, which re-establishes the expression of TJ proteins such as occludin and claudin-4 in the CNS to basal levels and inhibits the expression of PECAM-1. This study was based on experimental autoimmune encephalomyelitis, a mouse model of MS.
The study suggests that physical exercise maintains the integrity of the BBB by preserving tight junctions. Additionally, Schreibelt et al. [216] demonstrated that physical exercise in MS preserves the levels of claudin-4 and occludin in the spinal cord of mice, by inhibiting the production of reactive oxygen species and the induction of oxidative stress. Moreover, some studies have provided data that inhibiting glycogen synthase kinase-3β promotes TJ stability in brain endothelial cells by extending the half-life of occludin and claudin-5 and increasing their levels, which does not involve their gene regulation [217].
A study by Isla et al. [218] showed a favourable effect of voluntary exercise involving a reduction in glycogen synthase kinase-3β recruitment, resulting in protection of the BBB through TJs.
The inhibition of glycogen synthase kinase-3β has also anti-inflammatory effect on brain endothelial cells [219]. In addition to the barrier-enhancing role of glycogen synthase kinase-3β inhibitors, it gives a promise to their utility in repair and protection of the BBB.
Source:
Université Laval
